Table 3. Associations between changes in outcomes (BMI and GAF) from baseline and sociodemographic and clinical characteristics.
BMI (difference from baseline) | GAF (difference from baseline) | |||
---|---|---|---|---|
Variable | Mean (SD) | ANOVA p-value | Mean (SD) | ANOVA p-value |
Sex | ||||
Female | -0.1 (1.6) | 0.037* | 0.4 (7.2) | 0.859 |
Male | -0.8 (1.3) | 0.3 (5.5) | ||
Marital status | ||||
Married | -1.0 (0.5) | 0.143 | -2.4 (14.7) | 0.448 |
Single | -0.5 (0.2) | 0.9 (5.2) | ||
Divorced | 0.3 (0.5) | 0.5 (4.5) | ||
Diagnosis | ||||
Schizophrenia/schizophrenic disorder | -0.4 (1.4) | 0.611 | 0.8 (5.7) | 0.486 |
Schizoaffective disorder | -0.3 (1.7) | -1.4 (10.2) | ||
Variable | Correlation | p-value | Correlation | p-value |
Age | -0.15 | 0.194 | 0.17 | 0.106 |
Age at illness onset | -0.02 | 0.922 | -0.09 | 0.356 |
Duration of illness | 0.25 | 0.026* | 0.20 | 0.184 |
Metabolic risk index (difference from baseline) | 0.23 | 0.033* | -0.15 | 0.282 |
ANOVA = analysis of variance; BMI = body mass index; GAF = Global Assessment of Functioning; SD = standard deviation.
p < 0.05.